Evolution step-up growth trajectory upward trajectory
Pharma

How biosimilar developers are embracing next phase of US market

Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Vertex

Vertex gains FDA expansion of Casgevy to those ages 2 and older

Jul 6, 2026 11:30am
Food and Drug Administration

Regulatory tracker: HHS to revoke remaining COVID emergency nods

Jul 6, 2026 10:45am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: $71M US sales modeled for Foundayo debut

Jul 6, 2026 9:38am
Rising Stars in Pharma Marketing QA series header image

Know a rising star in pharma marketing? Nominate them here

Jul 2, 2026 8:00am
reputation rating ranking

Roche tops cancer reputation rankings as AstraZeneca climbs back

Jul 2, 2026 6:00am
More News

Tenpoint brings blurry vision hassles to life in new campaign

Jul 1, 2026 4:37pm

Lonza to expand ADC capacity, broaden collab with US drugmaker

Jul 1, 2026 3:22pm

Sanofi unit in Ireland dinged by FDA on Altuviiio production

Jul 1, 2026 2:52pm

Regulatory tracker: Sarepta's DMD drugs get FDA decision date

Jul 1, 2026 2:10pm